46.83% -0.0132

Ocean Biomedical Inc (OCEA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Perché OCEA Giù? Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Ocean Biomedical Inc Stock (OCEA) Company Profile

Ocean Biomedical Inc

Healthcare (1174)

Biotechnology (662)

Prossima data di guadagno

Ultimi documenti SEC

OCEA's Discussions on Twitter

Confronta OCEA con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
OCEA Ocean Biomedical Inc	0.0073	0	0	-82.19M	-8.35M	-3.0969
VRTX Vertex Pharmaceuticals Inc	440.87	115.95B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	509.72	56.52B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	309.70	39.44B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	542.15	35.14B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	247.08	28.51B	3.81B	-644.79M	-669.77M	-6.24

Ocean Biomedical Inc Borsa (OCEA) Ultime notizie

Ocean Biomedical Inc Azioni (OCEA) Dati Finanziari

Ocean Biomedical Inc (OCEA)

Ocean Biomedical Inc Stock (OCEA) Company Profile

Confronta OCEA con altri titoli

Ocean Biomedical Inc Borsa (OCEA) Ultime notizie

Ocean Biomedical faces license terminations over breaches By Investing.com - Investing.com Nigeria

Ocean Biomedical faces license terminations over breaches - Investing.com

Ocean Biomedical Faces License Termination Notice - TipRanks

SEC filing of the week: Ocean Biomedical posts $8.42M loss in Q1 - Providence Business News

Sidoti Events, LLC's Virtual June Small-Cap Conference - The Globe and Mail

Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value - Voice of Alexandria

Ocean Biomedical, Inc. SEC 10-Q Report - TradingView

Dr. Chirinjeev Kathuria - Smart Business Dealmakers

Ocean Biomedical (NASDAQ: OCEA) Announces $1 Million Falk Award for Malaria Drug Candidate Addressing Evolving Resistance to Artemisinin-Based Therapeutics to Chief Scientist Dr. Jonathan Kurtis - Seeking Alpha

Ocean Biomedical stock plunges to 52-week low of $0.28 - MSN

SEC filing of the week: Ocean Biomedical expands into energy, digital assets; delisted from Nasdaq - Providence Business News

United States shares higher at close of trade; Dow Jones Industrial Average up 1.07% - Investing.com India

Brown spinoff Ocean Biomedical, knocked off the Nasdaq, becomes a 'crypto and energy' company - The Business Journals

Ocean Biomedical expands into energy and crypto sectors - Investing.com Australia

why Ocean Biomedical Inc [OCEA] is a Good Choice for Investors After New Price Target of $18.50 - dbtnews.com

Ocean Biomedical expands into energy and crypto sectors By Investing.com - Investing.com South Africa

Ocean Biomedical Inc: Weathering Stock Market Storms with 6.06M Market Cap - investchronicle.com

Ocean Biomedical (OCEA) Expands into Power Infrastructure and Crypto - GuruFocus

Ocean Biomedical (OCEA) Diversifies into Power and Cryptocurrency Sectors | OCEA Stock News - GuruFocus

Ocean Biomedical Expands into Energy and Digital Asset Sectors to Accelerate Growth and Shareholder Value - The Manila Times

Ocean Biomedical Reveals Dramatic Business Transformation: Biotech Giant Expands into Energy and Digital Assets - Stock Titan

Ocean Biomedical Delays Yearly Report Filing - MSN

Ocean Biomedical stock plunges to 52-week low of $0.04 - Investing.com

Ocean Biomedical stock plunges to 52-week low of $0.04 By Investing.com - Investing.com Canada

Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Large Decrease in Short Interest - Defense World

Troubled Brown spinoff Ocean Biomedical racked up more losses in 2024 - The Business Journals

SEC filing of the week: Ocean Biomedical’s loss narrows to $9.4M in 2024 - Providence Business News

Ocean Biomedical, Inc. SEC 10-K Report - TradingView

Ocean Biomedical stock plunges to 52-week low of $0.05 - Investing.com

Ocean Biomedical stock plunges to 52-week low of $0.05 By Investing.com - Investing.com South Africa

Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Large Decline in Short Interest - Defense World

New CEO, several board members to step down from Ocean Biomedical - Providence Business News

Ocean Biomedical secures key patent in China for cancer therapy By Investing.com - Investing.com South Africa

Ocean Biomedical secures key patent in China for cancer therapy - Investing.com

Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China - The Manila Times

Ocean Biomedical Announces Grant on Patent Right - GlobeNewswire

Revolutionary Cancer Treatment Patent Secured: Dual-Target Antibody Breaks Ground in Chinese Market - Stock Titan

Four board members to exit troubled RI biotechProvidence Business First - The Business Journals

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Ocean Biomedical slashes conversion price on investor note By Investing.com - Investing.com Australia

Ocean Biomedical stock plunges to 52-week low of $0.07 By Investing.com - Investing.com Australia

Ocean Biomedical stock plunges to 52-week low of $0.07 - Investing.com

Ocean Biomedical announces board reshuffle amid resignations By Investing.com - Investing.com Australia

Ocean Biomedical Inc Azioni (OCEA) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a OCEA